NLRP3 and Alzheimer disease: NLRP3 inflammasome activation contributes to the inflammatory events in AD pathogenesis, since it enhances the secretion of IL-1β, which further promotes microglial activation and accumulation of inflammatory and neurotoxic factors resulting in a vicious cycle that exacerbates neurodegeneration [67].